Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Up 127.4% in February

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 48,900 shares, an increase of 127.4% from the February 13th total of 21,500 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

LABFF stock opened at C$65.86 on Friday. Laboratorios Farmaceuticos Rovi has a 1-year low of C$65.86 and a 1-year high of C$65.86. The business has a 50-day moving average price of C$65.86 and a 200 day moving average price of C$77.21.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.